Portal de investigación
Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Alvarez-Lerma, F
- Olaechea-Astigarraga, P
- Palomar-Martinez, M
- Catalan, M
- Nuvials, X
- Gracia-Arnillas, MP
- Seijas-Betolaza, I
- ENVIN-HELICS Study Grp
Grupos
Abstract
Invasive device-associated infections caused by Pseudomonas aeruginosa over 10 years (2007-2016) were assessed based on data from the ENVIN-HELICS registry (200 Spanish intensive care units). P. aeruginosa was the leading pathogen except in the last two years in which there was a slight decrease, with Escherichia coli as the leading aetiology. The rate of infections caused by P. aeruginosa remained between 12.0% and 14.6% throughout the study period. There was a significant increase of isolates resistant to imipenem, meropenem, ceftazidime, cefepime, and piperacillin-tazobactam. Multidrug-resistant and the sum of extensively drug- and pandrug-resistant strains also increased. Resistance to anti-pseudomonal antimicrobials remains a matter of concern. (C) 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0195-6701, 1532-2939
- Tipo:
- Article
- Páginas:
- 204-208
- Factor de Impacto:
- 1,474 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF HOSPITAL INFECTION W B SAUNDERS CO LTD
Citas Recibidas en Web of Science: 9
Documentos
- No hay documentos
Filiaciones
Keywords
- Pseudomonas aeruginosa; Invasive device-associated infection; Intensive care unit; Critically ill; Antimicrobial resistance; Anti-pseudomonal drugs
Proyectos asociados
IMPACTO DEL ECMO SOBRE LA FARMACOCINÉTICA DE LA ANIDULAFUNGINA.
Investigador Principal: FRANCISCA PÉREZ ESTEBAN
PFI-ANI-2013-01
Cita
Alvarez F,Olaechea P,Palomar M,Catalan M,Nuvials X,Gimeno R,Gracia MP,Seijas I,ENVIN GRP. Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years. J Hosp Infect. 2018. 100. (3):p. 204-208. IF:3,704. (1).